A new Netflix documentary called “Have a Good Trip: Adventures in Psychedelics” premiered on Netflix on May 11 this year and it is generating quite a buzz because of the topic it explores. In this documentary, several stars share their experiences of taking psychedelic drugs. Actors reenact those experiences being described by the celebrities, and experts delve into the science of why and what psychedelics can offer the medical community.
The lineup of celebrities who feature in the documentary is quite impressive. They include Ben Stiller, Sarah Silverman, and Natasha Lyonne. Even stars who have passed on, such as Carrie Fisher and Anthony Bourdain, have their psychedelic experiences reenacted…
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news on the latest developments in therapeutic psychedelics, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW has secured a unique strategic position in the therapeutic psychedelics market, and our team of journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the therapeutic psychedelics industry.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.